ProjectHeMiLa – Prophylactic treatment of hemiplegic migraine with Lamotrigine
Basic data
Acronym:
HeMiLa
Title:
Prophylactic treatment of hemiplegic migraine with Lamotrigine
Duration:
26/06/2017 to 26/06/2019
Abstract / short description:
Aim of the study: to evaluate the efficacy of lamotrigine in the prophylactic treatment of hemiplegic migraine with a focus on attack frequency.
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology and Epileptology
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Tübingen, Baden-Württemberg, Germany